Dailong Li

Shanghai Ship and Shipping Research Institute — China

Medicine · Health Sciences

5h-index88citations17works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(5), Lung Cancer Diagnosis and Treatment(3), Lung Cancer Treatments and Mutations(3), Liver Disease Diagnosis and Treatment(2), Cancer, Hypoxia, and Metabolism(2)

Publications17 total

Efficacy and safety of anlotinib plus EGFR-TKI for advanced non-small cell lung cancer with EGFR mutations: A meta-analysis of randomized controlled trials
Medicine·2025Open Access
MYB Proto-Oncogene Like 2 Promotes the Growth of Renal Carcinoma by Attenuating Endoplasmic Reticulum Stress and Activating Lipid Rafts
Archivos Españoles de Urología·2025
Efficacy and safety of osimertinib plus bevacizumab versus osimertinib alone for advanced non–small-cell lung cancer with EGFR mutations: A meta-analysis of randomized controlled trials
Medicine·2024· 4 citedOpen Access
The long-term efficacy and safety of apatinib are inferior to sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
Medicine·2024· 3 citedOpen Access
Sorafenib exhibits lower toxicity and comparable efficacy to sunitinib as a first-line treatment for metastatic renal cell carcinoma: A systematic review and meta-analysis
Medicine·2023· 5 citedOpen Access
Efficacy and safety of transarterial chemoembolization plus lenvatinib in the treatment of advanced hepatocellular carcinoma: A meta-analysis
Medicine·2023· 11 citedOpen Access
The Influence of Sino-US Trade Friction on U.S. Soybean Export
BCP Business & Management·2023· 1 citedOpen Access
Efficacy and safety of Kanglaite plus EGFR-TKI in the treatment of advanced non-small cell lung cancer: A meta-analysis of 13 RCTs
Medicine·2022· 2 citedOpen Access
Efficacy and safety of icotinib in the treatment of advanced EGFR mutation-positive nonsmall cell lung cancer: A meta-analysis of randomized controlled trials
Medicine·2022· 3 citedOpen Access
Prognostic and clinicopathological significance of nm23-H1 expression in non-small cell lung cancer: A meta-analysis
Medicine·2022· 2 citedOpen Access
Sintilimab combined with apatinib plus capecitabine in the treatment of unresectable hepatocellular carcinoma: A prospective, open-label, single-arm, phase II clinical study
Frontiers in Immunology·2022· 20 citedOpen Access
The effect of adjuvant chemoradiotherapy on survival after R0 resection for stage III-N2 nonsmall cell lung cancer: A meta-analysis
Medicine·2022· 3 citedOpen Access
Meta-analysis of the relationship between lymphovascular invasion and prognosis of patients with stage I gastric cancer
Medicine·2022· 3 citedOpen Access
Efficacy and safety of sorafenib combined with TACE in the treatment of advanced hepatocellular carcinoma: A meta-analysis.
PubMed·2022· 11 cited
Recombinant human endostatin injection (Endostar) combined with PF chemotherapy and sequential intensity-modulated radiotherapy is tolerable and improves prognosis of locally advanced nasopharyngeal carcinoma: a randomized, open, multicenter phase II clinical study.
PubMed·2022· 9 citedOpen Access
Bearing Habits of Acer truncatum and the Relationship Between Its Branch Characteristics and Fruiting Performance
Horticultural Science and Technology·2021· 1 citedOpen Access
<p>Development and Clinical Prospects of Techniques to Separate Circulating Tumor Cells from Peripheral Blood</p>
Cancer Management and Research·2020· 10 citedOpen Access

Frequent Co-authors

Lu Xu(7), Yaqi Pang(6), Chunlai Cheng(6), Xinhua Xu(5), Wanqiang Li(5), Lu Xu(4), Yuan Che(4), Siqi Liu(3), Dan Bao(2), Zhuo Chen(2), Cheng Tian(2), Sha Wan(2), Chunzhen Zhang(2), Jinxing Ji(1), Juan Hu(1), Ying Qian(1), Yinjie Zhou(1), Daojun Li(1), Xiaopeng Li(1), Xiaoling Zhang(1)